COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

North America

Sterile Development and Manufacturing

READ MORE

Lexington, USA

HPAPI Development and Manufacturing

READ MORE

Riverview, USA

Formulation Development & Manufacturing

READ MORE

Sellersville, USA

API Development & Manufacturing

READ MORE

Aurora, Canada

Europe

ADC Development & Manufacturing

READ MORE

Grangemouth, UK

API & Formulation Development & Manufacturing 

READ MORE

Morpeth, UK

Asia

Formulation Development

READ MORE

Ahmedabad PPDS, India

Drug Discovery

READ MORE

Ahmedabad PDS, India

API Development & Manufacturing

READ MORE

Ennore, India

API Development & Manufacturing

READ MORE

Digwal, India

Formulation Manufacturing

READ MORE

Pithampur, India

Formulation Manufacturing(Indian Market),

Vitamin & Nutritional Premixes

READ MORE

Mahad, India

API Development

READ MORE

Rabale, India

Peptide API Development & Manufacturing
USFDA

READ MORE

Turbhe, India

Vaccines and Biologics Process Development and Manufacturing

READ MORE

Hyderabad*, India

Our Locations

Shanghai, China - Sourcing Office Note: *Through PPS Minority Investment in Yapan Bio
Filter By: ALL FACILITIES Discovery Development Manufacturing ANTIBODY DRUG CONJUGATION